Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension.
Journal
Fluids and barriers of the CNS
ISSN: 2045-8118
Titre abrégé: Fluids Barriers CNS
Pays: England
ID NLM: 101553157
Informations de publication
Date de publication:
11 Jan 2023
11 Jan 2023
Historique:
received:
29
08
2022
accepted:
17
12
2022
entrez:
11
1
2023
pubmed:
12
1
2023
medline:
14
1
2023
Statut:
epublish
Résumé
Impaired cerebrospinal fluid (CSF) homeostasis is central to the pathogenesis of idiopathic intracranial hypertension (IIH), although the precise mechanisms involved are still not completely understood. The aim of the current study was to assess the CSF/serum ratio of neurofilament light chain levels (QNfL) as a potential indicator of functional CSF outflow obstruction in IIH patients. NfL levels were measured by single molecule array in CSF and serum samples of 87 IIH patients and in three control groups, consisting of 52 multiple sclerosis (MS) patients with an acute relapse, 21 patients with an axonal polyneuropathy (PNP), and 41 neurologically healthy controls (HC). QNfL was calculated as the ratio of CSF and serum NfL levels. Similarly, we also assessed the CSF/serum ratio of glial fibrillary acidic protein (QGFAP) levels to validate the QNfL data. Routine CSF parameters including the CSF/serum albumin ratio (QAlb) were determined in all groups. Lumbar puncture opening pressure of IIH patients was measured by manometry. CSF-NfL levels (r = 0.29, p = 0.008) and QNfL (0.40, p = 0.0009), but not serum NfL (S-NfL) levels, were associated with lumbar puncture opening pressure in IIH patients. CSF-NfL levels were increased in IIH patients, MS patients, and PNP patients, whereas sNfL levels were normal in IIH, but elevated in MS and PNP. Remarkably, QNfL (p < 0.0001) as well as QGFAP (p < 0.01) were only increased in IIH patients. QNfL was positively correlated with CSF-NfL levels (r = 0.51, p = 0.0012) and negatively correlated with S-NfL levels (r = - 0.51, p = 0.0012) in HC, while it was only positively associated with CSF-NfL levels in IIH patients (r = 0.71, p < 0.0001). An increase in blood-CSF barrier permeability assessed by QAlb did not lead to a decrease in QNfL in any cohort. The observed elevation of QNfL in IIH patients, which was associated with lumbar puncture opening pressure, indicates a reduced NfL transition from the CSF to serum compartment. This supports the hypothesis of a pressure-dependent CSF outflow obstruction to be critically involved in IIH pathogenesis.
Sections du résumé
BACKGROUND
BACKGROUND
Impaired cerebrospinal fluid (CSF) homeostasis is central to the pathogenesis of idiopathic intracranial hypertension (IIH), although the precise mechanisms involved are still not completely understood. The aim of the current study was to assess the CSF/serum ratio of neurofilament light chain levels (QNfL) as a potential indicator of functional CSF outflow obstruction in IIH patients.
METHODS
METHODS
NfL levels were measured by single molecule array in CSF and serum samples of 87 IIH patients and in three control groups, consisting of 52 multiple sclerosis (MS) patients with an acute relapse, 21 patients with an axonal polyneuropathy (PNP), and 41 neurologically healthy controls (HC). QNfL was calculated as the ratio of CSF and serum NfL levels. Similarly, we also assessed the CSF/serum ratio of glial fibrillary acidic protein (QGFAP) levels to validate the QNfL data. Routine CSF parameters including the CSF/serum albumin ratio (QAlb) were determined in all groups. Lumbar puncture opening pressure of IIH patients was measured by manometry.
RESULTS
RESULTS
CSF-NfL levels (r = 0.29, p = 0.008) and QNfL (0.40, p = 0.0009), but not serum NfL (S-NfL) levels, were associated with lumbar puncture opening pressure in IIH patients. CSF-NfL levels were increased in IIH patients, MS patients, and PNP patients, whereas sNfL levels were normal in IIH, but elevated in MS and PNP. Remarkably, QNfL (p < 0.0001) as well as QGFAP (p < 0.01) were only increased in IIH patients. QNfL was positively correlated with CSF-NfL levels (r = 0.51, p = 0.0012) and negatively correlated with S-NfL levels (r = - 0.51, p = 0.0012) in HC, while it was only positively associated with CSF-NfL levels in IIH patients (r = 0.71, p < 0.0001). An increase in blood-CSF barrier permeability assessed by QAlb did not lead to a decrease in QNfL in any cohort.
CONCLUSIONS
CONCLUSIONS
The observed elevation of QNfL in IIH patients, which was associated with lumbar puncture opening pressure, indicates a reduced NfL transition from the CSF to serum compartment. This supports the hypothesis of a pressure-dependent CSF outflow obstruction to be critically involved in IIH pathogenesis.
Identifiants
pubmed: 36631830
doi: 10.1186/s12987-022-00403-2
pii: 10.1186/s12987-022-00403-2
pmc: PMC9832777
doi:
Substances chimiques
Biomarkers
0
Neurofilament Proteins
0
neurofilament protein L
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3Subventions
Organisme : German Research Council (DFG)
ID : CRC-TR-128
Organisme : German Research Council (DFG)
ID : CRC-TR-128
Organisme : German Research Council (DFG)
ID : CRC-TR-128
Organisme : German Research Council (DFG)
ID : CRC-TR-128
Informations de copyright
© 2023. The Author(s).
Références
Acta Neuropathol. 2018 Jul;136(1):139-152
pubmed: 29754206
Am J Physiol. 1984 Jun;246(6 Pt 2):F835-44
pubmed: 6742132
Neurology. 2013 Sep 24;81(13):1159-65
pubmed: 23966248
JAMA. 2014 Apr 23-30;311(16):1641-51
pubmed: 24756514
Lancet Neurol. 2022 Mar;21(3):246-257
pubmed: 35182510
Neurology. 2015 Jun 2;84(22):2247-57
pubmed: 25934855
J Neurol Sci. 2001 Mar 1;184(2):101-22
pubmed: 11239944
J Neuroophthalmol. 2021 Mar 1;41(1):93-97
pubmed: 33034442
Eur J Neurol. 2021 Mar;28(3):1086-1089
pubmed: 33556229
Cell Mol Life Sci. 2021 Mar;78(6):2429-2457
pubmed: 33427948
Eur J Neurol. 2022 Sep;29(9):2810-2822
pubmed: 35638376
J Neurol. 2011 Nov;258(11):2014-9
pubmed: 21523461
Neurology. 2018 Sep 11;91(11):515-522
pubmed: 30201744
Lancet Neurol. 2016 Jan;15(1):78-91
pubmed: 26700907
Brain Res. 2016 Aug 1;1644:161-75
pubmed: 27188961
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
J Neurol. 2005 Sep;252(9):1067-73
pubmed: 15789126
Sci Transl Med. 2012 Aug 15;4(147):147ra111
pubmed: 22896675
Ann Clin Transl Neurol. 2020 Nov;7(11):2213-2220
pubmed: 33030817
Fluids Barriers CNS. 2022 Feb 3;19(1):9
pubmed: 35115036
Neurology. 2021 Jan 19;96(3):e412-e422
pubmed: 33087494
Brain Circ. 2018 Jan-Mar;4(1):14-18
pubmed: 30276331
Neurol Neuroimmunol Neuroinflamm. 2020 Feb 4;7(3):
pubmed: 32019769
Mol Neurodegener. 2019 Nov 4;14(1):39
pubmed: 31684998
Cephalalgia. 2020 Oct;40(12):1346-1354
pubmed: 32727204
Nature. 2015 Jul 16;523(7560):337-41
pubmed: 26030524
Nat Rev Neurol. 2018 Oct;14(10):577-589
pubmed: 30171200
Brain. 2020 Jul 1;143(7):1975-1998
pubmed: 32408345
Headache. 2014 Mar;54(3):445-58
pubmed: 24433163
Nat Commun. 2017 Nov 10;8(1):1434
pubmed: 29127332
Brain Commun. 2022 Feb 22;4(2):fcac045
pubmed: 35415607
J Neuroinflammation. 2018 Jul 18;15(1):209
pubmed: 30021640
Ann Clin Transl Neurol. 2016 Jul 01;3(8):623-36
pubmed: 27606344
Brain. 2021 Nov 29;144(10):2954-2963
pubmed: 34180982
Trends Neurosci. 2015 Jun;38(6):364-74
pubmed: 25975510
Stroke. 2019 Nov;50(11):3077-3084
pubmed: 31537188
Acta Neuropathol. 2018 Mar;135(3):387-407
pubmed: 29428972
Neurosci Lett. 2019 Apr 17;698:58-63
pubmed: 30599262